


p97-Inhibitors-Modulators-MCE.docx 免費下載
版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進行舉報或認領(lǐng)
文檔簡介
1、 HYPERLINK https:/www.MedChemE/Targets/p97.html p97VCP; Cdc48p97 (also referred to as VCP) is a highly conserved and abundant AAA+ (ATPases associated with diverse cellular activities) ATPasethat plays an essential role in cellular proteostasis. p97 participates in a large number of important cellul
2、ar activities, including (i)proteasomal degradation, through its roles in extracting proteins from membranes or molecular complexes; (ii) lysosomaldegradation via autophagy and endolysosomal sorting; (iii) membrane fusion; and (iv) regulation of intracellular signaling, cellproliferation, and surviv
3、al. These diverse cellular functions are powered by the chemical energy from ATP hydrolysis andcoordinated through the interaction of p97 with as many as 40 cofactors that recruit it to specific subcellular locations and todesignated substrates for their remodeling and processing.Mutations in p97 ha
4、ve been linked to a number of neurodegenerative diseases, and overexpression of wild type p97 is observed innumerous cancers. Furthermore, p97 activity has been shown to be essential for the replication of certain viruses, includingpoliovirus, herpes simplex virus (HSV), cytomegalovirus (CMV), and i
5、nfluenza. These observations highlight the potential fortargeting p97 as a therapeutic approach in neurodegeneration, cancer, and certain infectious diseases.www.MedChemE 1 HYPERLINK https:/www.MedChemE/Targets/p97.html p97 HYPERLINK https:/www.MedChemE/Targets/p97.html HYPERLINK https:/www.MedChemE
6、/Targets/p97.html Inhibitors HYPERLINK https:/www.MedChemE/CB-5083.html CB-5083Cat. No.: HY-12861 HYPERLINK https:/www.MedChemE/DBeQ.html DBeQ(JRF 12) Cat. No.: HY-15945CB-5083 is a first-in-class, potent, selective,and orally bioavailable inhibitor of the p97 AAAATPase/VCP. CB-5083 selectively inhi
7、bits p97through its D2 site with the IC of 11 nM.50DBeQ is a selective, potent, reversible, andATP-competitive p97 inhibitor, with an IC value50of 1.5 M and 1.6 M for p97(wt) and p97(C522A),respectively; DBeQ also inhibits Vps4 with anIC of 11.5 M.50Purity: 99.90%Clinical Data: Phase 1Size: 10 mM 1
8、mL, 5 mg, 10 mg, 50 mg, 100 mgPurity: 99.68%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 50 mg HYPERLINK https:/www.MedChemE/eeyarestatin-i.html Eeyarestatin HYPERLINK https:/www.MedChemE/eeyarestatin-i.html HYPERLINK https:/www.MedChemE/eeyarestatin-i.html I HYPERLINK https:
9、/www.MedChemE/eeyarestatin-i.html HYPERLINK https:/www.MedChemE/ML240.html ML240Cat. No.: HY-110078 Cat. No.: HY-19795Eeyarestatin I, a potent endoplasmicreticulum-associated protein degradation (ERAD)inhibitor, is a potent protein translocationinhibitor.ML240 is a potent p97 inhibitor, inhibiting p
10、97ATPase with IC value of 100 nM.50Purity: 98.14%Clinical Data: No Development ReportedSize: 5 mg, 10 mgPurity: 99.85%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/ML241-hydrochloride.html ML241 HYPERLINK https:/www.MedChemE/M
11、L241-hydrochloride.html HYPERLINK https:/www.MedChemE/ML241-hydrochloride.html hydrochloride HYPERLINK https:/www.MedChemE/ML241-hydrochloride.html HYPERLINK https:/www.MedChemE/msc1094308.html MSC1094308Cat. No.: HY-19797A Cat. No.: HY-123872ML241 hydrochloride is a potent p97 inhibitor,inhibiting
12、p97 ATPase with IC value of 100 nM.50MSC1094308 is a reversible and allostericinhibitor of the type II AAA ATPase humanubiquitin-directed unfoldase (VCP)/p97 and thetype I AAA ATPase VPS4B, with IC values of 0.7150M and 7.2 M for VPS4B and p97, respectively.Purity: 99.78%Clinical Data: No Developmen
13、t ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 25 mg, 50 mg, 100 mgPurity: 99.75%Clinical Data:Size: 10 mM 1 mL, 5 mg, 10 mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/NMS-859.html NMS-859 HYPERLINK https:/www.MedChemE/NMS-859.html HYPERLINK https:/www.MedChemE/NMS-873.html NMS-873Cat. No.: HY-15714 Cat
14、. No.: HY-15713NMS-859 is a potent, covalent VCP (p97)inhibitor, with IC s of 0.37 and 0.36 M for50wild-type VCP in the presence of 60 M and 1 mMATP in cells, respectively.NMS-873 is a potent, selective allosteric VCP/p97inhibitor with an IC value of 30 nM.50Purity: 98.01%Clinical Data: No Developme
15、nt ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 50 mg, 100 mgPurity: 99.86%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/p97-in-1.html p97-IN-1 HYPERLINK https:/www.MedChemE/p97-in-1.html HYPERLINK https:/www.MedChemE/upcdc-30245.html UPCD
16、C-30245Cat. No.: HY-128724 Cat. No.: HY-123636p97-IN-1 is a potent p97 inhibitor with an IC5098%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg2 Tel: 609-228-6898 Fax: 609-228-5909 Email: salesMedChemE HYPERLINK https:/www.MedChemE/vcp-p97-inhibitor-1.html VCP/p97 HYPERLINK https:/www.MedChemE/vcp-p97-inhibitor-1.html HYPERLINK https:/www.M
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準確性、安全性和完整性, 同時也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 出口檢修合同范本
- 加工定制合同范本
- 雙橋區(qū)短途配送合同范本
- 勞動合同范本文
- 公司股權(quán)轉(zhuǎn)讓合同范本
- 勞務(wù)住宿合同范本
- 勞動合同范本老版
- 書購書合同范本
- 保潔解除協(xié)議合同范本
- 勞務(wù)派遣終止合同范本
- 學(xué)校裝飾裝修工程施工方案
- 2025屆東方電氣集團校園招聘正式開啟筆試參考題庫附帶答案詳解
- DeepSeek科普學(xué)習(xí)解讀
- 2024年山東公務(wù)員考試申論試題(B卷)
- 2025年七下道德與法治教材習(xí)題答案
- 部編2024版歷史七年級下冊第二單元第12課《宋元時期經(jīng)濟的繁榮》檢測卷
- 家政服務(wù)員(母嬰護理員)五級模擬試題及答案
- 化工產(chǎn)品加工協(xié)議書范本
- 四年級數(shù)學(xué)(四則混合運算帶括號)計算題專項練習(xí)與答案
- 2025年湖北省宏泰國有資本投資運營集團有限公司招聘筆試參考題庫附帶答案詳解
- 2024年中考語文(云南卷)真題詳細解讀及評析
評論
0/150
提交評論